MICAL3
Basic information
Region (hg38): 22:17787649-18024561
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MICAL3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 135 | 146 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 135 | 11 | 6 |
Variants in MICAL3
This is a list of pathogenic ClinVar variants found in the MICAL3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-17790803-G-A | not specified | Uncertain significance (May 23, 2024) | ||
22-17790875-T-C | not specified | Uncertain significance (Jun 22, 2021) | ||
22-17791210-C-A | Benign (Mar 02, 2018) | |||
22-17791212-G-A | Likely benign (Sep 01, 2023) | |||
22-17791217-G-A | not specified | Uncertain significance (Jul 06, 2021) | ||
22-17791226-C-T | not specified | Uncertain significance (May 10, 2024) | ||
22-17808861-G-A | not specified | Uncertain significance (Dec 06, 2023) | ||
22-17808877-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
22-17808883-T-C | not specified | Uncertain significance (Nov 10, 2022) | ||
22-17808895-G-A | not specified | Uncertain significance (Sep 25, 2023) | ||
22-17808897-C-T | not specified | Uncertain significance (Oct 27, 2023) | ||
22-17808900-T-C | not specified | Uncertain significance (Jan 24, 2023) | ||
22-17810720-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
22-17810767-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
22-17810775-C-G | Likely benign (Sep 01, 2023) | |||
22-17810806-G-A | not specified | Uncertain significance (Nov 18, 2022) | ||
22-17816698-G-A | Uncertain significance (Nov 01, 2018) | |||
22-17816729-G-A | Likely benign (Oct 01, 2022) | |||
22-17816741-G-T | not specified | Uncertain significance (Apr 08, 2022) | ||
22-17816769-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
22-17816772-C-T | not specified | Uncertain significance (Dec 15, 2023) | ||
22-17817322-A-T | not specified | Uncertain significance (Oct 12, 2022) | ||
22-17817332-C-T | not specified | Likely benign (Jun 01, 2023) | ||
22-17817337-T-G | not specified | Uncertain significance (Jun 22, 2024) | ||
22-17817356-T-C | not specified | Uncertain significance (Mar 31, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MICAL3 | protein_coding | protein_coding | ENST00000441493 | 31 | 236911 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.995 | 0.00501 | 125051 | 0 | 80 | 125131 | 0.000320 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.75 | 1028 | 1.20e+3 | 0.858 | 0.0000777 | 12907 |
Missense in Polyphen | 385 | 542.31 | 0.70993 | 5776 | ||
Synonymous | -0.360 | 519 | 509 | 1.02 | 0.0000352 | 3993 |
Loss of Function | 7.17 | 17 | 90.7 | 0.188 | 0.00000489 | 1069 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00107 | 0.000954 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000115 | 0.000110 |
Finnish | 0.000378 | 0.000324 |
European (Non-Finnish) | 0.000399 | 0.000353 |
Middle Eastern | 0.000115 | 0.000110 |
South Asian | 0.000205 | 0.000196 |
Other | 0.000188 | 0.000164 |
dbNSFP
Source:
- Function
- FUNCTION: Monooxygenase that promotes depolymerization of F-actin by mediating oxidation of specific methionine residues on actin to form methionine-sulfoxide, resulting in actin filament disassembly and preventing repolymerization. In the absence of actin, it also functions as a NADPH oxidase producing H(2)O(2). Seems to act as Rab effector protein and plays a role in vesicle trafficking. Involved in exocytic vesicles tethering and fusion: the monooxygenase activity is required for this process and implicates RAB8A associated with exocytotic vesicles. Required for cytokinesis. Contributes to stabilization and/or maturation of the intercellular bridge independently of its monooxygenase activity. Promotes recruitment of Rab8 and ERC1 to the intercellular bridge, and together these proteins are proposed to function in timely abscission. {ECO:0000269|PubMed:21596566, ECO:0000269|PubMed:24440334}.;
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- loftool
- rvis_EVS
- 0.41
- rvis_percentile_EVS
- 76.52
Haploinsufficiency Scores
- pHI
- 0.163
- hipred
- N
- hipred_score
- 0.352
- ghis
- 0.415
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0814
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mical3
- Phenotype
Gene ontology
- Biological process
- exocytosis;cytoskeleton organization;cell cycle;actin filament depolymerization;cell division;oxidation-reduction process
- Cellular component
- nucleus;nucleoplasm;spindle;cytosol;plasma membrane;cell cortex;midbody;cell projection
- Molecular function
- actin binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;Rab GTPase binding;metal ion binding;FAD binding